Trial Number

500-15

Condition

Leukemia

Participant Age Range

1 Year to 30 Years

Participant Gender

Any

Enrolling Participants

No

Overview

“AALL1331: Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND#117467, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)”

This randomized phase III trial studies how well blinatumomab works compared with standard combination chemotherapy in treating patients with B-cell acute lymphoblastic leukemia that has returned after a period of improvement (relapsed). Monoclonal antibodies, such as blinatumomab, may interfere with the ability of tumor cells to grow and spread. It is not yet known whether standard combination chemotherapy is more effective than blinatumomab in treating relapsed B-cell acute lymphoblastic leukemia.

Provider

Jacqueline N Casillas, MD

Hematology-Oncology - Pediatric
Long Beach, Torrance
View Profile

Location

Miller Children’s & Women’s Hospital Long Beach

2801 Atlantic Avenue
Long Beach
(562) 933-5437
Location Details

Related Clinical Trials

Click on the category you are interested in.

Cancer Care Pediatric Care Pediatric Specialty Care Miller Children’s & Women’s Hospital Long Beach
Name
Address
Enter Trial number from the area just below the marquee.
How would you prefer to be contacted?
How did you hear about us?
This registration is for:
CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.